SEARCH

SEARCH BY CITATION

References

  • Abi-akar, R., El-Rassi, I., Karam, M., Jassar, Y., Slim, R. & Jebara, V. (2011) Treatment of Heyde's Syndrome by aortic valve replacement. Current Cardiology Reviews, 7, 4749.
  • Abshire, T. (2009) The role of prophylaxis in the management of von Willebrand disease: today and tomorrow. Thrombosis Research, 124(Suppl. 1), S15S19.
  • Abshire, T.C., Federici, A.B., Alvárez, M.T., Bowen, J., Carcao, M.D., Cox Gill, J., Key, N.S., Kouides, P.A., Kurnik, K., Lail, A.E., Leebeek, F.W., Makris, M., Mannucci, P.M., Winikoff, R. & Berntorp, E.; VWD PN. (2013) Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN). Haemophilia, 19, 7681.
  • Alikhan, R. & Keeling, D. (2009) Von Willebrand disease, angiodysplasia and atorvastatin. British Journal of Haematology, 149, 159160.
  • Berntorp, E. (2008) Prophylaxis in von Willebrand disease. Haemophilia, 14(Suppl 5), 4753.
  • Berntorp, E. & Petrini, P. (2005) Long-term prophylaxis in von Willebrand disease. Blood Coagulation & Fibrinolysis, 16(Suppl. 1), S23S26.
  • Berntorp, E. & Windyga, J..; European Wilate Study Group. (2009) Treatment and prevention of acute bleedings in von Willebrand disease–efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate. Haemophilia, 15, 122130.
  • Blackshear, J.L., Schaff, H.V., Ommen, S.R., Chen, D. & Nichols, W.L. (2011) Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy. Mayo Clinic Proceedings, 86, 219224.
  • Bowers, M., McNulty, O. & Mayne, E. (2000) Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. British Journal of Haematology, 108, 524527.
  • van Breevoort, D., van Agtmaal, E.L., Dragt, B.S., Gebbinck, J.K., Dienava-Verdoold, I., Kragt, A., Bierings, R., Horrevoets, A.J., Valentijn, K.M., Eikenboom, J.C., Fernandez-Borja, M., Meijer, A.B. & Voorberg, J. (2012) Proteomic screen identifies IGFBP7 as a novel component of endothelial cell- specific Weibel-Palade bodies. Journal of Proteome Research, 11, 29252936.
  • Cass, A.J., Bliss, B.P., Bolton, R.P. & Cooper, B.T. (1980) Gastrointestinal bleeding, angiodysplasia of the colon and acquired von Willebrand's disease. British Journal of Surgery, 67, 639641.
  • Castaman, G., Federici, A.B., Tosetto, A., La Marca, S., Stufano, F., Mannucci, P.M. & Rodeghiero, F. (2012) Different bleeding risk in type 2 A and 2 M Von Willebrand disease: a two-year prospective study in 107 patients. Journal of Thrombosis & Haemostasis, 10, 632638.
  • Chey, W.D., Hasler, W.L. & Bockenstedt, P.L. (1992) Angiodysplasia and von Willebrand's disease type IIB treated with estrogen/progesterone therapy. American Journal of Hematology, 41, 276279.
  • Coppola, A., Cimino, E., Conca, P., De Simone, C., Tufano, A., Tarantino, G., Cerbone, A.M. & Di Minno, G. (2006) Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding. Haemophilia, 12, 9094.
  • Federici, A.B. (2008) Prophylaxis of bleeding episodes in patients with von Willebrand's disease. Blood Transfusion, 6(Suppl. 2), s26s32.
  • Federici, A.B., Stabile, F., Castaman, G., Canciani, M.T. & Mannucci, P.M. (1998) Tretament of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood, 92, 27072711.
  • Federici, A.B., Rand, J.H., Bucciarelli, P., Budde, U., van Genderen, P.J., Mohri, H., Meyer, D., Rodeghiero, F. & Sadler, J.E..; Subcommittee on von Willebrand Factor. (2000) Acquired von Willebrand syndrome: data from an international registry. Thrombosis & Haemostasis, 84, 345349.
  • Federici, A.B., Gianniello, F. & Mannucci, P.M. (2005) Secondary long-term prophylaxis in severe patients with von Willebrand's disease: an Italian cohort study. Haematologica Reports, 1, 1520.
  • Federici, A.B., Castaman, G., Franchini, M., Morfini, M., Zanon, E., Coppola, A., Tagliaferri, A., Boeri, E., Mazzucconi, M.G., Rossetti, G. & Mannucci, P.M. (2007) Clinical use of Haemate P in inherited von Willebrand disease: a cohort study on 100 Italian patients. Haematologica, 92, 944951.
  • Franchini, M. & Lippi, G. (2007a) The role of von Willebrand factor in hemorrhagic and thrombotic disorders. Critical Reviews in Clinical Laboratory Sciences, 44, 115149.
  • Franchini, M. & Lippi, G. (2007b) Acquired von Willebrand syndrome: an update. American Journal of Hematology, 82, 368375.
  • Franchini, M., Targher, G. & Lippi, G. (2007) Prophylaxis in von Willebrand disease. Annals of Hematology, 86, 699704.
  • Fressinaud, E. & Meyer, D. (1993) International survey of patients with von Willebrand disease and angiodysplasia. Thrombosis & Haemostasis, 70, 546.
  • Gritti, G., Cortelezzi, A., Bucciarelli, P., Rezzonico, F., Lonati, S., La Marca, S., Silvestris, I. & Federici, A.B. (2011) Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis. American Journal of Hematology, 86, 650656.
  • Heyde, E.C. (1958) Gastrointestinal bleeding in aortic stenosis. New England Journal of Medicine, 259, 196.
  • Hirri, H.M., Green, P.J. & Lindsay, J. (2006) Von Willebrand's disease and angiodysplasia treated with thalidomide. Haemophilia, 12, 285286.
  • Iannuzzi, M.C., Hidaka, N., Boehnke, M., Bruck, M.E., Hanna, W.T., Collins, F.S. & Ginsburg, D. (1991) Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr). American Journal of Human Genetics, 48, 757763.
  • Lamboley, V., Zabraniecki, L., Sie, P., Pourrat, J. & Fournié, B. (2002) Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a literature review . Joint Bone Spine, 69, 6267.
  • Lenting, P., Casari, C., Christophe, O.D. & Denis, C.V. (2012) Von Willebrand factor: the old, the new and the unknown. Journal of Thrombosis & Haemostasis, 10, 24282437.
  • Li, M. & Losardo, D.W. (2007) Statins and the endothelium. Vascular Pharmacology, 46, 19.
  • Makris, M. (2006) Gastrointestinal bleeding in von Willebrand disease. Thrombosis Research, 118(Suppl 1), S13S17.
  • Mannucci, P.M., Pareti, F.I., Holmberg, L., Nilsson, I.M. & Ruggeri, Z.M. (1976) Studies on the prolonged bleeding time in von Willebrand's disease. Journal of Laboratory & Clinical Medicine, 88, 662671.
  • Mannucci, P.M., Franchini, M., Castaman, G. & Federici, A.B.;Italian Association of Hemophilia Centers. (2009) Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfusion, 7, 117126.
  • Morris, E.S., Hampton, K.K., Nesbitt, I.M., Preston, F.E., Thomas, W.E.G. & Makris, M. (2001) The management of von Willebrand's disease associated gastrointestinal dysplasia. Blood Coagulation & Fibrinolysis, 12, 143148.
  • Nomikou, E., Tsevrenis, V., Gafou, A., Bellia, M. & Theodossiades, G. (2009) Type IIb von Willebrand disease with angiodysplasias and refractory gastrointestinal bleeding successfully treated with thalidomide. Haemophilia, 15, 13401342.
  • Odouard, S., Christophe, O.D., de Groot, P.G., Denis, C.V. & Lenting, P.J. (2012) Identification of galectin-1 and galectin-3 as novel partner for von Willebrand factor. Arteriosclerosis Thrombosis & Vascular Biology, 32, 894901.
  • Pareti, F.I., Lattuada, A., Bressi, C., Zanobini, M., Sala, A., Steffan, A. & Ruggeri, Z.M. (2000) Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation, 102, 12901295.
  • Pate, G.E. & Mulligan, A. (2004) An epidemiological study of Heyde's syndrome: an association between aortic stenosis and gastrointestinal bleeding. Journal of Heart Valve Disease, 13, 713716.
  • Pi, L., Shenoy, A.K., Liu, J., Kim, S., Nelson, N., Xia, H., Hauswirth, W.W., Petersen, B.E., Schultz, G.S. & Scott, E.W. (2012) CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB Journal, 26, 33653379.
  • Quick, A.J. (1967) Telangiectasia: its relationship to the Minot-von Willebrand syndrome. American Journal of Medical Science, 254, 585.
  • Rahmani, R., Rozen, P., Papo, J., Iellin, A. & Seligsohn, U. (1990) Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia. Israeli Journal of Medical Science, 26, 504509.
  • Rosborough, T.K. & Swaim, W.R. (1978) Acquired von Willebrand's disease, platelet-release defect and angiodysplasia. American Journal of Medicine, 65, 96100.
  • Ruggeri, Z.M. (2001) Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Practice & Research Clinical Haematology, 14, 257279.
  • Sadler, J.E. (2003) Aortic stenosis, von Willebrand factor and bleeding. New England Journal of Medicine, 349, 323325.
  • Satoh, Y., Kita, H., Kihira, K., Mutoh, H., Osawa, H., Satoh, K., Ido, K., Sakata, Y. & Sugano, K. (2004) Gastrointestinal angiodysplasia in a patient with type 2 von Willebrand's disease and analysis of exon 28 of the von Willebrand factor gene. American Journal of Gastroenterology, 99, 24952498.
    Direct Link:
  • Siragusa, S., Malato, A., Lo Coco, L., Cigna, V., Saccullo, G., Abbene, I., Anastasio, R., Caramazza, D., Patti, R., Arcara, M. & Di Vita, G. (2008) Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management. Haemophilia, 14, 150152.
  • Slaughter, M.S. (2010) Hematologic effects of continuous flow left ventricular assist devices. Journal of Cardiovascular Translational Research, 3, 618624.
  • Sohal, M. & Laffan, M. (2008) Von Willebrand disease and angiodysplasia responding to atorvastatin. British Journal of Haematology, 142, 309.
  • Starke, R.D., Ferraro, F., Paschalaki, K.E., Dryden, N.H., McKinnon, T.A., Sutton, R.E., Payne, E.M., Haskard, D.O., Hughes, A.D., Cutler, D.F., Laffan, M.A. & Randi, A.M. (2011) Endothelial von Willebrand factor regulates angiogenesis. Blood, 117, 10711080.
  • Veyradier, A., Balian, A., Wolf, M., Giraud, V., Montembault, S., Obert, B., Dagher, I., Chaput, J.C., Meyer, D. & Naveau, S. (2001) Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract. Gastroenterology, 129, 346353.
  • Vincentelli, A., Susen, S., Le Tourneau, T., Six, I., Fabre, O., Juthier, F., Bauters, A., Decoene, C., Goudemand, J., Prat, A. & Jude, B. (2003) Acquired von Willebrand syndrome in aortic stenosis. New England Journal of Medicine, 349, 343349.
  • Warkentin, T.E., Moore, J.C. & Morgan, D.G. (1992) Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet, 340, 3537.
  • Warkentin, T.E., Moore, J.C., Anand, S.S., Lonn, E.M. & Morgan, D.G. (2003) Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfusion Medicine Reviews, 17, 272286.
  • Wautier, J.L., Caen, J.P. & Rymer, R. (1976) Angiodysplasia in acquired von Willebrand disease. Lancet, 2, 973.